Evogene Ltd.

To reach its goals, Evogene established a unique predictive computational biology platform which relies on deep multi-disciplinary know how in biology and chemistry, combined with cutting edge computational technologies that allows the creation, integration and analysis of dedicated Big-Data for the purpose of systematic discoveries in our chosen areas of focus.This unique technology has evolved over the last decade and has been enhanced during the years with technological advancements in Artificial Intelligence, Deep Learning and Big Data, and allows Evogene to reveal genomic sequences for seed traits, small molecules for Ag-Chemicals and various bacteria for Ag-Biologicals.Evogene’s business model is composed of independent or collaborative R&D with advanced development and commercialization conducted by our partners. Evogene currently has strategic collaborations and licensing agreements with world-leading agricultural companies, such as: BASF, Corteva, ICL, Monsanto and more

Bank Name Evogene Ltd.
Stock Exchange NASDAQ
Symbol
EVGN
Sector Healthcare
Industry Agricultural Chemicals
Country United States
World Region Amarica
Chairman
CEO Mr. Ofer Haviv CPA
Employees 165
Website www.evogene.com
Registered Year 2007

UpdateContent
UpdateContent
UpdateContent